Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

Saved in:
Bibliographic Details
Title: Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Authors: White HD (AUTHOR), Ohman EM (AUTHOR), Lincoff AM (AUTHOR), Bertrand ME (AUTHOR), Colombo A (AUTHOR), McLaurin BT (AUTHOR), Cox DA (AUTHOR), Pocock SJ (AUTHOR), Ware JA (AUTHOR), Manoukian SV (AUTHOR), Lansky AJ (AUTHOR), Mehran R (AUTHOR), Moses JW (AUTHOR), Stone GW (AUTHOR), White, Harvey D1 (AUTHOR), Ohman, E Magnus (AUTHOR), Lincoff, A Michael (AUTHOR), Bertrand, Michel E (AUTHOR), Colombo, Antonio (AUTHOR), McLaurin, Brent T (AUTHOR)
Source: Journal of the American College of Cardiology (JACC). Sep2008, Vol. 52 Issue 10, p807-814. 8p.
Database: Academic Search Ultimate
Description
ISSN:07351097
DOI:10.1016/j.jacc.2008.05.036